LKL International BhdXKLS:0182 EPS without NRI is RM-0.07 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 662 Medical Devices & Instruments companies, LKL International Bhd ranks worse than 98.79% on this metric.
LKL International Bhd's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was RM-0.01.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was RM-0.07.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -75.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for LKL International Bhd's EPS without NRI or its related term are showing as below:
XKLS:0182'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -75.6 Med: 8.5 Max: 22.4
Current: -75.6
During the past 10 years, LKL International Bhd's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 22.40% per year. The lowest was -75.60% per year. And the median was 8.50% per year.
XKLS:0182's 3-Year EPS without NRI Growth Rate is ranked worse than 98.79% of 662
companies
in the Medical Devices & Instruments industry
Industry Median: 8.15
vs XKLS:0182: -75.60
LKL International Bhd's EPS (Basic) for the
three
months ended in Mar. 2026 was RM-0.01.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was RM-0.07.
LKL International Bhd (XKLS:0182) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
LKL International Bhd EPS without NRI Related Terms
LKL International Bhd EPS without NRI Historical Data
* Premium members only.
The historical data trend for LKL International Bhd's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0182 vs ISRG, BDX, MDLN: EPS without NRI Comparison
For the Medical Instruments & Supplies subindustry, LKL International Bhd's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LKL International Bhd PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where LKL International Bhd's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LKL International Bhd (XKLS:0182) has a EPS without NRI of RM-0.07 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on LKL International Bhd and its competitors. According to the industry distribution chart, LKL International Bhd ranks #654 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 98.8%.
Is LKL International Bhd's EPS without NRI too high?
LKL International Bhd's current EPS without NRI is RM-0.07. Based on the distribution chart, LKL International Bhd ranks #654 out of 662 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does LKL International Bhd's EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, LKL International Bhd ranks #654 out of 662 companies for EPS without NRI. This places LKL International Bhd in the lower half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on LKL International Bhd and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LKL International Bhd's current EPS without NRI is RM-0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.03 — trading 40% below its estimated fair value. The current EPS without NRI is RM-0.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current EPS without NRI is RM-0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0182 has been successfully added to your 